HRP20190219T1 - Spojevi za tretman pretilosti i postupci za njihovu uporabu - Google Patents
Spojevi za tretman pretilosti i postupci za njihovu uporabuInfo
- Publication number
- HRP20190219T1 HRP20190219T1 HRP20190219TT HRP20190219T HRP20190219T1 HR P20190219 T1 HRP20190219 T1 HR P20190219T1 HR P20190219T T HRP20190219T T HR P20190219TT HR P20190219 T HRP20190219 T HR P20190219T HR P20190219 T1 HRP20190219 T1 HR P20190219T1
- Authority
- HR
- Croatia
- Prior art keywords
- procedures
- compounds
- adult treatment
- adult
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361908998P | 2013-11-26 | 2013-11-26 | |
| EP14816018.7A EP3074033B1 (en) | 2013-11-26 | 2014-11-25 | Compounds for the treatment of obesity and methods of use thereof |
| PCT/US2014/067393 WO2015081093A1 (en) | 2013-11-26 | 2014-11-25 | Compounds for the treatment of obesity and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20190219T1 true HRP20190219T1 (hr) | 2019-03-22 |
Family
ID=52134396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20190219TT HRP20190219T1 (hr) | 2013-11-26 | 2014-11-25 | Spojevi za tretman pretilosti i postupci za njihovu uporabu |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20160375039A1 (enExample) |
| EP (1) | EP3074033B1 (enExample) |
| JP (2) | JP6672157B2 (enExample) |
| AU (2) | AU2014354831B2 (enExample) |
| CA (1) | CA2931826C (enExample) |
| CY (1) | CY1122551T1 (enExample) |
| DK (1) | DK3074033T3 (enExample) |
| ES (1) | ES2709976T3 (enExample) |
| HR (1) | HRP20190219T1 (enExample) |
| HU (1) | HUE042196T2 (enExample) |
| LT (1) | LT3074033T (enExample) |
| PL (1) | PL3074033T3 (enExample) |
| PT (1) | PT3074033T (enExample) |
| RS (1) | RS58422B1 (enExample) |
| SI (1) | SI3074033T1 (enExample) |
| SM (1) | SMT201900064T1 (enExample) |
| TR (1) | TR201901299T4 (enExample) |
| WO (1) | WO2015081093A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170209408A1 (en) * | 2014-04-03 | 2017-07-27 | The Children's Medical Center Corporation | Hsp90 inhibitors for the treatment of obesity and methods of use thereof |
| CN106008657B (zh) * | 2016-05-20 | 2017-11-21 | 天津中医药大学 | 苦蘵苦素i及提取方法及用途 |
| IT201800005336A1 (it) * | 2018-05-14 | 2019-11-14 | Composizioni per uso nel trattamento dell’obesità | |
| WO2021072139A1 (en) * | 2019-10-11 | 2021-04-15 | Massachusetts Institute Of Technology | Formulations for gastrointestinal delivery of oligonucleotides |
| CN113599502A (zh) * | 2021-07-22 | 2021-11-05 | 廖儒佳 | 一种醉茄素a和瘦素的组合物及其在制备预防和或治疗出血性脑卒中药物中的应用 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA791659B (en) | 1978-04-17 | 1980-04-30 | Ici Ltd | Process and apparatus for spraying liquid |
| GB8504253D0 (en) | 1985-02-19 | 1985-03-20 | Ici Plc | Electrostatic spraying apparatus |
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| MY107937A (en) | 1990-02-13 | 1996-06-29 | Takeda Chemical Industries Ltd | Prolonged release microcapsules. |
| US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
| US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
| US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5827734A (en) | 1995-01-20 | 1998-10-27 | University Of Washington | Materials and methods for determining ob protein in a biological sample |
| US5552524A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5552523A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| US5521283A (en) | 1995-01-31 | 1996-05-28 | Eli Lilly And Company | Anti-obesity proteins |
| US5532336A (en) | 1995-01-31 | 1996-07-02 | Eli Lilly And Company | Anti-obesity proteins |
| US5552522A (en) | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
| WO1996040912A1 (en) | 1995-06-07 | 1996-12-19 | Amgen Inc. | Ob protein compositions and method |
| AU695934B2 (en) | 1995-06-30 | 1998-08-27 | Eli Lilly And Company | Methods for treating diabetes |
| WO1997006816A1 (en) | 1995-08-17 | 1997-02-27 | Amgen Inc. | Methods of reducing or maintaining reduced levels of blood lipids using ob protein compositions |
| US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
| US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
| CA2236163A1 (en) | 1995-11-22 | 1997-05-29 | Amgen Inc. | Methods of increasing lean tissue mass using ob protein compositions |
| AU2670897A (en) | 1996-04-04 | 1997-10-29 | Amgen, Inc. | Fibulin pharmaceutical compositions and related methods |
| EP0921820A4 (en) * | 1996-06-20 | 2003-01-15 | Merck & Co Inc | GENETERAPY FOR OBESITY |
| WO1998008512A1 (en) | 1996-08-30 | 1998-03-05 | Amgen Inc. | Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor |
| JP2001500869A (ja) | 1996-09-20 | 2001-01-23 | ヘキスト、アクチェンゲゼルシャフト | 第ｉｉ種糖尿病におけるインスリン耐性を治療するためのレプチンアンタゴニストの使用 |
| ES2221019T3 (es) | 1996-10-31 | 2004-12-16 | Takeda Chemical Industries, Ltd. | Preparacion de liberacion mantenida. |
| EP1835030A1 (en) | 1996-12-20 | 2007-09-19 | Amgen, Inc. | OB fusion protein compositions and methods |
| IL132380A0 (en) | 1997-04-17 | 2001-03-19 | Amgen Inc | Compositions comprising conjugates of stable active human ob protein with antibody fc chain and methods |
| CA2293504A1 (en) | 1997-06-06 | 1998-12-10 | Valur Emilsson | Use of leptin antagonists for the treatment of diabetes |
| US7052678B2 (en) | 1997-09-15 | 2006-05-30 | Massachusetts Institute Of Technology | Particles for inhalation having sustained release properties |
| US6541033B1 (en) | 1998-06-30 | 2003-04-01 | Amgen Inc. | Thermosensitive biodegradable hydrogels for sustained delivery of leptin |
| CA2337667C (en) | 1998-08-10 | 2008-04-29 | Amgen Inc. | Dextran-leptin conjugates, pharmaceutical compositions and related methods |
| CA2344623A1 (en) | 1998-10-02 | 2000-04-13 | Amgen Inc. | Method to determine a predisposition to leptin treatment |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| EP1151102B1 (en) | 1999-02-12 | 2006-04-19 | Amgen Inc. | Glycosylated leptin compositions and related methods |
| ATE475094T1 (de) | 2001-10-22 | 2010-08-15 | Amgen Inc | Verwendung von leptin zur behandlung von lipoatrophie im menschen und verfahren zur bestimmmung einer prädisposition gegenüber der behandlung |
| WO2004039832A2 (en) | 2002-10-31 | 2004-05-13 | Albany Medical College | Leptin-related peptides |
| JP4585186B2 (ja) * | 2003-07-31 | 2010-11-24 | 杏林製薬株式会社 | 肥満、糖尿病及び脂質代謝異常の新規な予防又は治療剤 |
| JP2009541423A (ja) * | 2006-06-23 | 2009-11-26 | ラボラトリオス・デル・ドクトル・エステベ・ソシエダッド・アノニマ | コリンエステラーゼ阻害剤と５‐ｈｔ６レセプター親和性の化合物との組合せ |
| WO2010030395A2 (en) * | 2008-09-15 | 2010-03-18 | Whitehead Institute For Biomedical Research | Withaferin a analogs and uses thereof |
| WO2010053655A2 (en) * | 2008-11-07 | 2010-05-14 | University Of Kansas | Therapeutic methods with withaferin a and analogs |
| US8598339B2 (en) * | 2011-02-01 | 2013-12-03 | University Of Kansas | Withanolide isolated from Physalis longifolia and analogs and methods of use thereof |
-
2014
- 2014-11-25 PT PT14816018T patent/PT3074033T/pt unknown
- 2014-11-25 AU AU2014354831A patent/AU2014354831B2/en not_active Ceased
- 2014-11-25 LT LTEP14816018.7T patent/LT3074033T/lt unknown
- 2014-11-25 PL PL14816018T patent/PL3074033T3/pl unknown
- 2014-11-25 WO PCT/US2014/067393 patent/WO2015081093A1/en not_active Ceased
- 2014-11-25 HR HRP20190219TT patent/HRP20190219T1/hr unknown
- 2014-11-25 ES ES14816018T patent/ES2709976T3/es active Active
- 2014-11-25 JP JP2016554826A patent/JP6672157B2/ja active Active
- 2014-11-25 US US15/039,743 patent/US20160375039A1/en not_active Abandoned
- 2014-11-25 HU HUE14816018A patent/HUE042196T2/hu unknown
- 2014-11-25 EP EP14816018.7A patent/EP3074033B1/en active Active
- 2014-11-25 TR TR2019/01299T patent/TR201901299T4/tr unknown
- 2014-11-25 DK DK14816018.7T patent/DK3074033T3/en active
- 2014-11-25 SM SM20190064T patent/SMT201900064T1/it unknown
- 2014-11-25 RS RS20190124A patent/RS58422B1/sr unknown
- 2014-11-25 CA CA2931826A patent/CA2931826C/en active Active
- 2014-11-25 SI SI201431046T patent/SI3074033T1/sl unknown
-
2018
- 2018-01-23 AU AU2018200517A patent/AU2018200517B2/en not_active Ceased
-
2019
- 2019-02-05 CY CY20191100155T patent/CY1122551T1/el unknown
- 2019-12-16 JP JP2019226600A patent/JP2020059744A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018200517A1 (en) | 2018-02-15 |
| DK3074033T3 (en) | 2019-02-11 |
| CA2931826A1 (en) | 2015-06-04 |
| JP6672157B2 (ja) | 2020-03-25 |
| JP2016537431A (ja) | 2016-12-01 |
| CY1122551T1 (el) | 2021-01-27 |
| EP3074033A1 (en) | 2016-10-05 |
| RS58422B1 (sr) | 2019-04-30 |
| WO2015081093A1 (en) | 2015-06-04 |
| PL3074033T3 (pl) | 2019-08-30 |
| CA2931826C (en) | 2021-11-16 |
| HUE042196T2 (hu) | 2019-06-28 |
| US20160375039A1 (en) | 2016-12-29 |
| ES2709976T3 (es) | 2019-04-22 |
| SMT201900064T1 (it) | 2019-02-28 |
| AU2014354831B2 (en) | 2017-10-26 |
| LT3074033T (lt) | 2019-02-25 |
| SI3074033T1 (sl) | 2019-03-29 |
| TR201901299T4 (tr) | 2019-02-21 |
| JP2020059744A (ja) | 2020-04-16 |
| PT3074033T (pt) | 2019-02-08 |
| EP3074033B1 (en) | 2018-11-07 |
| AU2014354831A1 (en) | 2016-06-09 |
| AU2018200517B2 (en) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283943A (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k related disorders | |
| IL268987B (en) | System for glaucoma treatment | |
| PL3542798T3 (pl) | Aceklidyna do zastosowania w leczeniu starczowzroczności | |
| HRP20181628T1 (hr) | Spojevi i postupci za njihovu upotrebu | |
| HRP20181392T1 (hr) | Heterociklični spojevi i njihova uporaba | |
| SI3033086T1 (sl) | Kombinirana terapija za zdravljenje raka | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| HRP20170840T1 (hr) | Supstituirani ksantini i metode njihove uporabe | |
| HRP20182138T1 (hr) | Modificirani serpini za liječenje poremećaja s krvarenjem | |
| HRP20180478T1 (hr) | Crenolanib za liječenje flt3 mutiranih proliferativnih poremećaja | |
| LT3007726T (lt) | Tautopatijos gydymo būdai | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| SI2991633T1 (sl) | Terapija za bakteriofagi | |
| HRP20181122T1 (hr) | Postupak za pripremu jopamidola | |
| HRP20181879T1 (hr) | Spojevi za liječenje pretilosti i postupci za njihovu upotrebu | |
| IL242220A0 (en) | Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias | |
| PL3082845T3 (pl) | Sposoby i kompozycje do leczenia neuropatii obwodowych | |
| HRP20181980T1 (hr) | Ciklezonid za liječenje dišnih puteva kod konja | |
| BR112016008387A2 (pt) | Conjunto de absorvente descartável, e, artigo absorvente | |
| EP2839068A4 (en) | Clothes treatment apparatus | |
| PL2948137T3 (pl) | Sposoby leczenia zwłóknienia i nowotworów | |
| EP2994184C0 (en) | An unravelable catheter | |
| DK2976101T3 (da) | Behandlingsfremgangsmåde | |
| DK3041506T3 (da) | Behandlingsfremgangsmåde | |
| HRP20181181T1 (hr) | Postupak obrade i liječenja lišmenioze uporabom feksinidazola |